Study rejects biologic age as limiting factor for stem cell transplants

More than 40 percent of older patients with acute myeloid leukemia (AML) can remain in long-term cancer remission through a modified, less aggressive approach to donor stem cell transplantation, according to the results of a phase 2 study.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1PdYu8P

No comments:

Post a Comment